logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (iv) All outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates23.246.160.559.556.054.150.539.47105620306
Cocaine11.421.025.729.932.634.136.031.0333468436
Stimulants3.44.93.12.52.52.31.47.35720879
Hypnotics and sedatives0.90.81.12.03.65.07.616.92012641
Hallucinogens0.20.10.10.00.10.10.00.018872
Volatile substances0.50.20.10.00.10.20.10.125059
Cannabis 59.426.38.95.54.43.53.42.0344307611
Other substances 1.00.60.50.60.70.71.03.3960446
Total2125466610339961404465913151144534314796238450

Notes:

 : indicates data not available 

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LU, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain and Malta refer to 2006.Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009